Phase I study of a MUC1 vaccine composed of different doses of MUC1 peptide with SB-AS2 adjuvant in resected and locally advanced pancreatic cancer

Ramesh K. Ramanathan(University of Pittsburgh), Kenneth Lee(UPMC Health System), John McKolanis(University of Pittsburgh), Elizabeth Hitbold(University of Pittsburgh), Wolfgang H. Schraut(UPMC Health System), A. James Moser(UPMC Health System), Elizabeth Warnick(University of Pittsburgh), Theresa L. Whiteside(UPMC Hillman Cancer Center), Jennifer Osborne(University of Pittsburgh), Hyoung Kim(University of Pittsburgh), Roger Day(CACI International (United States)), Monica Troetschel(University of Pittsburgh), Olivera J. Finn(University of Pittsburgh)
Cancer Immunology Immunotherapy
September 14, 2004
Cited by 219Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis